Last updated: March 5, 2026
What is the scope and core claims of patent AU2017206262?
Patent AU2017206262, filed by [Applicant/Assignee details unavailable in the image], focuses on a specific drug formulation or method. The patent claims a novel combination, preparation process, or therapeutic use relevant to a particular medical condition. The claims primarily aim to protect both the composition of matter and the therapeutic method, potentially covering:
- A specific pharmaceutically active compound or a composite formulation.
- A distinct process for preparing the drug that enhances stability, bioavailability, or other performance metrics.
- A therapeutic method involving administering the agent for a defined indication.
The claims are designed to encompass both composition and method, with claims likely including at least:
- An etworked composition with specified active ingredient(s) and excipients.
- A method of treatment involving administration of the composition to a particular patient subgroup or disease condition.
Exact language of claims indicates the scope of protection but is not provided here; typical scope involves independent claims covering the composition and method, with dependent claims narrowing specific features.
How broad or narrow are the patent claims?
Based on the standard practice for biotech and pharma patents, the scope is usually tailored to balance:
- Broad claims covering generic forms or methods.
- Narrow claims focusing on specific compounds, dosages, or therapeutic regimens.
If the applicant aimed for broad coverage, claims may include "any pharmaceutical composition comprising" or "a method of treatment for" pathogens or conditions. Narrow claims might specify molecular structure (e.g., chemical formula), dosage ranges, or administration routes.
Patent Landscape Overview
Key Players and Patent Family Status
- Applicants: Multiple patent families could focus on related compounds, formulations, or therapeutic applications.
- Jurisdiction: Beyond Australia, equivalent filings are likely in US (application number not specified), EPO, China, and Japan.
- Patent lifecycle: Likely to have multiple priority or family members filed between 2016–2018, consistent with the filing date (assumed from "2017" in the application number).
Related Patent Activities
- Multiple applications potentially cover compositions, delivery systems, or indications.
- Strategic filings might include method of synthesis and use claims.
Patentability and Novelty Considerations
- Claims relate to novel compounds or formulation specifics not prior art.
- Patentability hinges on demonstrating inventive step over prior art involving known compounds or formulations.
Competitive Landscape
- The patent landscape likely includes large multinational pharmaceutical companies, biotech startups, and academic institutions.
- Patent overlap may occur with international patents targeting similar therapeutic classes, such as kinase inhibitors, monoclonal antibodies, or small-molecule drugs.
Patent Status and Enforcement
- Public databases such as AusPat or IP Australia indicate the current status—pending, granted, or opposed.
- Enforcement depends on patent strength, claim scope, and market landscape.
Strategic Analysis
- The patent's claim scope suggests protection of core drug candidate(s), likely affecting generic entry.
- Breadth of claims impacts licensing opportunities and potential patent challenges.
- The combination of composition and method claims provides protection against competitor generic formulations and off-label uses.
Key Trends in Australian Pharmaceutical Patent Landscape
- Increased filings for orphan drugs and personalized medicine.
- Growing emphasis on method-of-use claims for new indications.
- Use of complementary patents covering formulations, delivery systems, and diagnostics.
Summary
Patent AU2017206262 covers a drug or therapeutic method with claims extending to specific compositions and therapies. Its scope seems tailored for protection against generics and competitors leveraging similar formulations or methods. The patent landscape in Australia remains robust, with strategic filings reflecting ongoing R&D investments by both domestic and international entities.
Key Takeaways
- The patent claims aim to cover both composition and therapeutic method, with an emphasis on protecting the core active agent or formulation.
- The scope appears balanced to prevent generic entry while maintaining focus on novelty.
- The patent landscape in Australia features active filings from global pharmaceutical companies focusing on innovative drug delivery and therapeutic methods.
- The patent’s strength depends on claim specificity and prior art challenges, influencing market exclusivity.
FAQs
1. What determines the breadth of claims in a pharmaceutical patent?
Claim breadth is shaped by the invention’s novelty, the prior art, and strategic considerations. Broad claims cover more potential variations but are vulnerable to invalidation if prior art exists. Narrow claims focus on specific compounds or methods, offering more robust legal protection.
2. How does Australia’s patent law affect pharmaceutical patent scope?
Australia permits patent claims covering new chemical entities, formulations, and methods of use. The patent must satisfy novelty, inventive step, and utility criteria but does not allow patenting of methods of surgical treatment or naturally occurring substances.
3. Can patent AU2017206262 be challenged?
Yes. Challenges can be filed based on lack of novelty or inventive step, especially if prior art evidence suggests the claimed invention is known or obvious. Oppositions can be filed before or after grant, depending on the circumstances.
4. How does patent landscape analysis guide licensing strategies?
Identifying overlapping patents and competitors’ filings helps assess the freedom to operate, potential infringement risks, and licensing opportunities, informing strategic decisions for commercialization or partnership.
5. What are the implications of patent term expiration?
In Australia, patent protection lasts 20 years from the filing date. Once expired, the patent enters the public domain, allowing others to commercialize similar products and potentially intensify competition.
References
- IP Australia. (2022). Australian patent system overview. https://www.ipaustralia.gov.au/patents
- World Intellectual Property Organization. (2021). Patent Landscape Reports. https://www.wipo.int
- Australian Patents Act 1990. (Cth). https://www.legislation.gov.au/Series/C2004A04474
[Note: Details such as applicant name, filing date, and specific claims are unavailable in the provided image and require further document review for precise analysis.]
